These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14277225)

  • 41. [Acute pulmonary embolism emergency. Confirming diagnosis, administering heparin, begin thrombolysis].
    Leuchte HH; Behr J
    MMW Fortschr Med; 2003 May; 145(20):39-43. PubMed ID: 12822229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic thrombolysis for acute pulmonary embolism.
    Bartel B
    Hosp Pract (1995); 2015; 43(1):22-7. PubMed ID: 25559613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis.
    Nakamura S; Takano H; Kubota Y; Asai K; Shimizu W
    J Thromb Haemost; 2014 Jul; 12(7):1086-95. PubMed ID: 24829097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 45. THE EFFECTS OF FIBRIN FORMATION AND ALTERATIONS IN THE CLOTTING MECHANISM ON THE DEVELOPMENT OF METASTASES.
    CLIFFTON EE; AGOSTINO D
    Vasc Dis; 1965 Jan; 2():43-52. PubMed ID: 14252944
    [No Abstract]   [Full Text] [Related]  

  • 46. BLOCKING OF INHIBITION OF FIBRINOLYSIN BY MERCURIALS AND OXIDIZING AGENTS.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1965 Mar; 109():607-14. PubMed ID: 14320504
    [No Abstract]   [Full Text] [Related]  

  • 47. STUDIES ON ACTION OF PLASMIN UPON THE LIVER.
    YAMAMOTO S
    Jpn Circ J; 1964 Feb; 28():110-2. PubMed ID: 14122694
    [No Abstract]   [Full Text] [Related]  

  • 48. [Fibrinolytic treatment of pulmonary embolism].
    Tomkowski WZ
    Pneumonol Alergol Pol; 1997; 65(11-12):849-53. PubMed ID: 9760803
    [No Abstract]   [Full Text] [Related]  

  • 49. Fibrinolytic and Anticoagulation Therapy in Patients Undergoing Ultrasound-Assisted Catheter-Directed Thrombolysis for Pulmonary Embolism.
    Terry KJ; Buckley LF; Aldemerdash A; Fanikos J; Dell'Orfano H
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):132-135. PubMed ID: 28891451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of thrombolytic therapy in the treatment of pulmonary embolism.
    Pini M
    Haematologica; 1997; 82(3):258-61. PubMed ID: 9234569
    [No Abstract]   [Full Text] [Related]  

  • 52. Thrombolytic therapy in patients with submassive pulmonary embolism.
    Dalen JE
    N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542064
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pulmonary artery embolism].
    Petrovskiĭ BV; Malinovskiĭ NN
    Khirurgiia (Mosk); 1998; (6):7-11. PubMed ID: 9680795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of pulmonary embolism by fibrinolysin. Experimental research].
    COURBIER R; TORRESANI J; MONTIES JR; PATRICE Y; FIGARELLA J; GARABEDIAN B
    Ann Chir; 1962 Feb; 16():231-8. PubMed ID: 13881735
    [No Abstract]   [Full Text] [Related]  

  • 55. [STUDY OF THE ANTIFIBRINOLYTIC PROPERTIES OF KUNITZ'S PANCREATIC INHIBITOR. (TESTS IN VITRO AND IN VIVO)].
    GIBELLI A; SCARDI F
    Gazz Int Med Chir; 1963 Oct; 67():2105-16. PubMed ID: 14095279
    [No Abstract]   [Full Text] [Related]  

  • 56. In vivo fibrinolytic activity and pharmacology of various plasmin (fibrinolysin) preparations.
    BACK N; AMBRUS JL; GOLDSTEIN S; HARRISSON JW
    Circ Res; 1956 Jul; 4(4):440-3. PubMed ID: 13330188
    [No Abstract]   [Full Text] [Related]  

  • 57. [The fibrinolytic activity of the blood in thromboembolic diseases. Clinical research with a new drug, the trypsin-heparin molecular compound].
    VIDILI F; FERRARA L
    Minerva Cardioangiol; 1963 Apr; 11():204-9. PubMed ID: 13997097
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of patients with acute coronary insufficiency with thrombolytic preparations (fibrinolysin and thrombolytin)].
    Khalfen ESh; Orlova NP
    Ter Arkh; 1968 Dec; 40(12):48-52. PubMed ID: 4247402
    [No Abstract]   [Full Text] [Related]  

  • 59. Thrombolytic therapy for acute pulmonary embolism.
    Sharma G; Kothari SS; Bahl VK
    Indian Heart J; 2002; 54(6):667-71. PubMed ID: 12674177
    [No Abstract]   [Full Text] [Related]  

  • 60. Fibrinolytic enzymes in thrombo-embolic disorders.
    CLIFFTON EE
    Semin Int; 1961; 10(2)():2-9. PubMed ID: 13879951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.